NYSTATIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 20 adverse event reports in the FDA FAERS database where NYSTATIN was used for Psoriasis.
Most Reported Side Effects for NYSTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 330 | 17.4% | 29 | 69 |
| Off label use | 149 | 7.9% | 19 | 53 |
| Dyspnoea | 148 | 7.8% | 11 | 54 |
| Candida infection | 145 | 7.7% | 14 | 19 |
| Nausea | 120 | 6.3% | 7 | 60 |
| Rash | 120 | 6.3% | 16 | 32 |
| Drug hypersensitivity | 102 | 5.4% | 7 | 25 |
| Cough | 91 | 4.8% | 1 | 17 |
| Asthma | 90 | 4.8% | 3 | 24 |
| Condition aggravated | 90 | 4.8% | 13 | 24 |
| Pulmonary embolism | 86 | 4.6% | 10 | 12 |
| Pain | 82 | 4.3% | 4 | 28 |
| Fatigue | 81 | 4.3% | 4 | 41 |
| Pruritus | 81 | 4.3% | 6 | 30 |
| Sinusitis | 81 | 4.3% | 4 | 29 |
Other Indications for NYSTATIN
Product used for unknown indication (626)
Oral candidiasis (166)
Candida infection (164)
Fungal infection (87)
Prophylaxis (38)
Antifungal prophylaxis (34)
Rash (28)
Pain in extremity (27)
Fungal skin infection (24)
Mouth ulceration (21)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)